Selkirk Pharma, founded by industry experts in sterile fill/finish, delivers on its promise to be the most reliable manufacturer of injectable drug products, from compounding to product release. A new purpose-built, unidirectional facility in Spokane, WA features best-in-class equipment, including ultra-high-yield Bausch and Stroebel VarioSys filler with SKAN isolator technology for harmonized GMP compliance with US FDA and EU Annex 1 regulations. To support our rapid clinical trials materials program, ClinFAST™, a highly skilled and invested workforce offers in-house analytical and microbiology testing, regulatory support, and real-time QA review for on-time, in-full delivery regardless of volume. Vial Capacity Now Available!
Investor insights
Funding rounds participated in
$24M sweet spot round size
Investor type
Basic info
Industry
Sectors
Date founded
2018
Funding rounds raised
Total raised
$24M
from investors over 1 rounds
Selkirk Pharma raised $24M on October 6, 2023